Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Invested Capital (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Invested Capital readings, the most recent being $10.9 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 102.86% to $10.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.9 million, a 102.86% increase, with the full-year FY2025 number at $10.9 million, up 102.86% from a year prior.
  • Invested Capital hit $10.9 million in Q4 2025 for Lucid Diagnostics, down from $25.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $54.7 million in Q4 2021 to a low of -$20.0 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $11.4 million (2024), compared with a mean of $13.5 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 1687.83% in 2022 and later tumbled 145.21% in 2025.
  • Lucid Diagnostics' Invested Capital stood at $54.7 million in 2021, then crashed by 57.9% to $23.0 million in 2022, then plummeted by 110.03% to -$2.3 million in 2023, then soared by 333.28% to $5.4 million in 2024, then skyrocketed by 102.86% to $10.9 million in 2025.
  • The last three reported values for Invested Capital were $10.9 million (Q4 2025), $25.8 million (Q3 2025), and $7.9 million (Q2 2025) per Business Quant data.